Abaloparatide

Overview

Abaloparatide (Tymlos) is a 34-amino acid synthetic analog of parathyroid hormone-related protein (PTHrP(1-34)) with modifications that confer improved selectivity for the RG conformation of PTH1R. FDA-approved in 2017 for postmenopausal women with osteoporosis at high fracture risk, abaloparatide demonstrated a 43% reduction in vertebral fracture risk (vs. 65% for teriparatide) with a potentially more favorable balance between anabolic bone formation and resorption activation. Its unique PTH1R conformational selectivity may translate to a shorter 'anabolic window' before significant bone resorption occurs.

Mechanism of Action

Abaloparatide binds PTH1R with selectivity for the RG (relaxed, active G protein-coupled) receptor conformation over the R0 (uncoupled) conformation. This differs from teriparatide which binds both conformations. The RG-selective binding produces strong, transient cAMP activation followed by rapid internalization, creating sharp cAMP pulses rather than sustained elevation. This pulsatile signaling pattern may more closely mimic endogenous PTHrP activity (a local paracrine factor in bone) versus endocrine PTH activity, potentially explaining a more rapid anabolic response with less sustained resorption activation.

Potential Benefits

• Anabolic bone formation in postmenopausal osteoporosis
• 43% reduction in vertebral fracture risk (Phase III)
• Potentially faster onset than teriparatide
• Unique RG-selective PTH1R mechanism
• Transdermal patch formulation in development (Mikart)

Research Dosage Notes

The following reflects doses used in published research studies. This is not medical advice.

80 mcg SC daily in the abdomen. Maximum 2 years lifetime use.

Amino Acid Sequence

Side Effects & Safety

• Injection site reactions (more common than teriparatide)
• Dizziness and palpitations
• Hypercalciuria
• Nausea
• Black box warning: osteosarcoma (same class warning as teriparatide)

Synergistic Compounds

The following compounds have been studied alongside Abaloparatide for potential complementary or synergistic effects:

Related Peptides

Learn More

References & Further Reading

• [object Object]
• [object Object]